MMH
ABBV icon

Menora Mivtachim Holdings’s AbbVie ABBV Stock Holding History

Menora Mivtachim Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248M Buy
1,139,168
+24,355
+2% +$5.4M 1.17% 24
2025
Q4 		$255M Hold
1,114,813
– – 1.2% 21
2025
Q3 		$258M Hold
1,114,813
– – 1.31% 22
2025
Q2 		$207M Hold
1,114,813
– – 1.19% 29
2025
Q1 		$234M Sell
1,114,813
-442,000
-28% -$85.9M 1.51% 20
2024
Q4 		$277M Hold
1,556,813
– – 1.73% 16
2024
Q3 		$307M Buy
1,556,813
+17,204
+1% +$3.21M 1.94% 17
2024
Q2 		$264M Hold
1,539,609
– – 1.79% 17
2024
Q1 		$280M Buy
1,539,609
+360,664
+31% +$62.2M 2.1% 15
2023
Q4 		$183M Buy
1,178,945
+274,000
+30% +$39.9M 1.54% 22
2023
Q3 		$135M Sell
904,945
-16,400
-2% -$2.41M 1.22% 37
2023
Q2 		$124M Sell
921,345
-3,000
-0.3% -$440K 1.15% 33
2023
Q1 		$147M Sell
924,345
-7,025
-0.8% -$1.07M 1.52% 23
2022
Q4 		$151M Hold
931,370
– – 2.54% 13
2022
Q3 		$125M Hold
931,370
– – 2.36% 15
2022
Q2 		$143M Hold
931,370
– – 2.6% 11
2022
Q1 		$151M Buy
931,370
+192,050
+26% +$27.9M 2.18% 15
2021
Q4 		$100M Hold
739,320
– – 1.36% 28
2021
Q3 		$79.8M Buy
739,320
+3,000
+0.4% +$343K 1.17% 33
2021
Q2 		$82.9M Hold
736,320
– – 1.19% 34
2021
Q1 		$79.7M Sell
736,320
-755,280
-51% -$80.8M 1.31% 33
2020
Q4 		$160M Buy
1,491,600
+342,600
+30% +$32.9M 2.79% 11
2020
Q3 		$101M Buy
1,149,000
+544,000
+90% +$51.2M 2.24% 18
2020
Q2 		$59.4M Buy
+605,000
New +$53.3M 1.46% 32

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Menora Mivtachim Holdings's ABBV Position: Q1 2026 in Review

Menora Mivtachim Holdings increased its AbbVie (ABBV) stake by 2.2% in Q1 2026, buying an estimated $5.4M and bringing the position to 1,139,168 shares worth $248M. The position accounts for 1.17% of the portfolio, ranked #24.

Menora Mivtachim Holdings first reported a position in ABBV in Q2 2020 and has held it in 24 quarters since. The position peaked at $307M in Q3 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Menora Mivtachim Holdings held 1,139,168 shares of AbbVie worth $248M as of Q1 2026.
  • Menora Mivtachim Holdings bought 24,355 AbbVie shares in Q1 2026, an estimated $5.4M.
  • AbbVie made up 1.17% of Menora Mivtachim Holdings's portfolio in Q1 2026, its #24 holding.
  • Menora Mivtachim Holdings first reported a position in AbbVie in Q2 2020 and has held it in 24 quarters since.
  • Menora Mivtachim Holdings's AbbVie position peaked at $307M in Q3 2024.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Menora Mivtachim Holdings's 13F filing for Q1 2026, filed 14 May 2026.